MedTrace Logo

Drug-Drug Interaction Between DW4421 and Amoxicillin/Clarithromycin

NCT07382661 · Status: NOT_YET_RECRUITING · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 36

Last updated 2026-02-04

No results posted yet for this study

Summary

Drug-Drug Interaction between DW4421 and Amoxicillin/Clarithromycin

Conditions

  • Healthy Adult Volunteers

Interventions

DRUG

DW4421

1 tablet will be orally administered

DRUG

DW4421-1

2 capsules will be orally administered

DRUG

DW4421-2

1 tablet will be orally administered

Sponsors & Collaborators

  • Daewon Pharmaceutical Co., Ltd.

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
19 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-02-28
Primary Completion
2026-05-31
Completion
2026-10-31

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07382661 on ClinicalTrials.gov